Taken together, this study establishes a useful and comprehensive rodent model of breast cancer that combines menopausal status, tumor growth, surgery, chemotherapy, and aromatase inhibitors in sequence and results in inflammation, neuroimaging alterations, and reduced locomotor activity consistent with many breast cancer patients. The gene discussed is CYP19A1; the disease is breast cancer.